Notably, the PI3K pathway is thought to be activated in greater than 80% of rhabdomyosarcomas, and both TP53 and PTEN function are lost in approximately 67% of leiomyosarcomas [12,13]. This evidence concerns the gene PTEN and leiomyosarcoma.